UnitedHealth Group (NYSE:UNH) – Equities researchers at Cantor Fitzgerald upped their FY2018 earnings per share estimates for UnitedHealth Group in a note issued to investors on Wednesday, April 18th. Cantor Fitzgerald analyst S. Halper now expects that the healthcare conglomerate will post earnings per share of $12.60 for the year, up from their prior forecast of $12.40. Cantor Fitzgerald has a “Overweight” rating and a $300.00 price objective on the stock. Cantor Fitzgerald also issued estimates for UnitedHealth Group’s FY2019 earnings at $14.30 EPS.
Other equities analysts also recently issued research reports about the stock. Deutsche Bank increased their price target on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Piper Jaffray reiterated a “buy” rating and issued a $259.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. Evercore ISI restated an “outperform” rating and set a $255.00 target price (up from $235.00) on shares of UnitedHealth Group in a report on Friday, January 12th. Sanford C. Bernstein set a $275.00 target price on shares of UnitedHealth Group and gave the company a “buy” rating in a report on Wednesday. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “sell” rating to a “hold” rating in a report on Thursday. Three analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $251.13.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.91 by $0.13. The business had revenue of $55.19 billion during the quarter, compared to the consensus estimate of $54.90 billion. UnitedHealth Group had a net margin of 5.41% and a return on equity of 22.06%. The business’s revenue was up 13.3% compared to the same quarter last year. During the same quarter last year, the firm posted $2.37 EPS.
Several institutional investors and hedge funds have recently added to or reduced their stakes in UNH. KBC Group NV lifted its position in UnitedHealth Group by 4.7% during the third quarter. KBC Group NV now owns 323,799 shares of the healthcare conglomerate’s stock valued at $63,416,000 after buying an additional 14,672 shares in the last quarter. DekaBank Deutsche Girozentrale lifted its position in UnitedHealth Group by 2.0% during the third quarter. DekaBank Deutsche Girozentrale now owns 489,647 shares of the healthcare conglomerate’s stock valued at $95,646,000 after buying an additional 9,810 shares in the last quarter. Toronto Dominion Bank lifted its position in UnitedHealth Group by 12.6% during the fourth quarter. Toronto Dominion Bank now owns 432,508 shares of the healthcare conglomerate’s stock valued at $95,350,000 after buying an additional 48,565 shares in the last quarter. Bainco International Investors lifted its position in UnitedHealth Group by 5.4% during the third quarter. Bainco International Investors now owns 82,676 shares of the healthcare conglomerate’s stock valued at $16,192,000 after buying an additional 4,202 shares in the last quarter. Finally, GWM Advisors LLC lifted its position in UnitedHealth Group by 20.3% during the fourth quarter. GWM Advisors LLC now owns 9,297 shares of the healthcare conglomerate’s stock valued at $2,090,000 after buying an additional 1,571 shares in the last quarter. 86.78% of the stock is currently owned by institutional investors and hedge funds.
In other news, Director Kenneth Irwin Shine sold 202 shares of UnitedHealth Group stock in a transaction dated Thursday, April 19th. The shares were sold at an average price of $237.42, for a total transaction of $47,958.84. Following the completion of the sale, the director now directly owns 28,948 shares in the company, valued at $6,872,834.16. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, March 19th. The stock was sold at an average price of $224.36, for a total transaction of $2,243,600.00. Following the completion of the sale, the director now directly owns 1,771,257 shares in the company, valued at $397,399,220.52. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 77,019 shares of company stock valued at $17,879,133. Insiders own 0.89% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.